Recuro Health Supports SIIA Annual Meeting: Provides Voluntary COVID-19 Antigen Rapid Testing for Attendees: CEO Michael Gorton Panel Presenter

Recuro Health is proud to support the SIIA annual conference by providing COVID-19 antigen rapid tests on a voluntary basis to all attendees during the three-day conference: SIIA’s 41^st Annual National Educational Conference, October 3-5, 2021, Austin, TX.

Recuro’s COVID-19 rapid testing solution has generated wide receptivity among the nation’s employers, including federal and state governments and corporate healthcare decision-makers. In fact, Recuro was among 12 technology companies selected by the U.S. Department of Health and Human Services (HHS) and recognized for developing digital solutions to ensure that COVID-19 diagnostic testing data is efficiently, securely and accurately transmitted to key stakeholders.

Here’s what distinguishes a best-of-breed testing solution for at-home and on-site COVID testing:

Provides a structured, end-to-end process that delivers more than just bulk testing supplies
Meets all regulatory requirements (including FDA and OSHA) for employees’ safe return-to-work and participation in crucial meetings, events and conventions
Offers front-end intake via a secure web portal access to capture registration, identity and information
Tethers eligibility to test distribution and administration
Immediacy of real-time results — 20-25 minutes
Provides monitoring, tracking and back-end reporting
Ensures easy access to physicians – anytime — via message-based or video interactions
Assures transparent and competitive pricing

Michael Gorton, Recuro Health CEO Participates on SIIA Digital Health Panel

Digital health was widely adopted during the pandemic and added to the care delivery system to improve access, quality and affordability along with patient outcomes. The investment in virtual care and digital health has skyrocketed with a $15 billion investment in the first six months of this year alone and could be worth nearly $221 billion by 2026. That’s why a digital health session is being featured at the SIIA meeting. Michael Gorton, founder and CEO of Recuro, joins healthcare leaders on a live panel presentation “Transforming Employee Health Care Experience Through Digital Health Advancements (LIVE).”

Gorton is joined by panelists Dea Belazi, president and CEO, AscellaHealth; Jeff Dobro, M.D., FACR, chief innovation officer, Transcarent; and Chris Michalak, CEO, Virgin Pulse. Attendees will learn more about digital strategies, including telehealth and remote patient monitoring, as panelists share their perspectives on how digital solutions impact chronic care management, the importance of digital solutions for medication adherence and compliance and how employers can support telehealth use among employees. “This year’s SIIA national conference offers a ‘blended’ experience, featuring high-quality educational content delivered via a sophisticated virtual platform, with a combination of live and pre-recorded sessions scheduled during the session,” says Gorton. “As Recuro emphasizes its focus on digital health solutions, our entire team is committed to patient-centric care, and we support payers in their quest to reduce costs for patient care delivery and improve clinical outcomes.”

The Best Digital Health Solution

The digital health solution needs to be tailored so employers, payers and providers can build their own digital health platform with targeted solutions for certain populations. The best digital health solution can be fully integrated with the curated suite of capabilities that Recuro offers, including virtual care/behavioral telehealth, at-home lab and onsite testing, genomics and more. While telehealth will continue to help manage the care of patients across all demographics, advanced digital technologies have even greater potential to dramatically change the lives of countless patients. Digital health solutions translate into earlier interventions that improve care delivery and result in better health outcomes.